Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xuesaitong enteric-coated capsules in stable angina
CTR20130598Phase 2Active
- Sponsor
- Weihe Pharmaceutical
- Start
- Nov 2013
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of panax notoginseng in coronary arteriosclerosis and angina pectoris (2 arms), sponsored by Weihe Pharmaceutical. Started Nov 2013; status: active.
02
Drugs
panax notoginseng
03
Conditions
coronary arteriosclerosisangina pectoris
Beyond the preview
Go deeper on CTR20130598.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20130598.